ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 46 filers reported holding ARATANA THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,632,000 | -21.0% | 923,722 | +3.0% | 0.00% | 0.0% |
| Q3 2016 | $8,391,000 | +52.7% | 896,521 | +3.1% | 0.00% | 0.0% |
| Q2 2016 | $5,495,000 | +30.9% | 869,516 | +14.4% | 0.00% | 0.0% |
| Q1 2016 | $4,197,000 | +1.0% | 760,273 | +2.1% | 0.00% | 0.0% |
| Q4 2015 | $4,157,000 | -35.2% | 744,986 | -1.7% | 0.00% | 0.0% |
| Q3 2015 | $6,413,000 | -18.3% | 758,003 | +46.1% | 0.00% | 0.0% |
| Q2 2015 | $7,845,000 | -2.4% | 518,824 | +3.4% | 0.00% | 0.0% |
| Q1 2015 | $8,037,000 | +24.8% | 502,006 | +38.9% | 0.00% | 0.0% |
| Q4 2014 | $6,439,000 | +125.0% | 361,330 | +26.7% | 0.00% | – |
| Q3 2014 | $2,862,000 | -32.7% | 285,096 | +4.7% | 0.00% | -100.0% |
| Q2 2014 | $4,250,000 | -27.4% | 272,265 | -13.6% | 0.00% | 0.0% |
| Q1 2014 | $5,851,000 | +204.6% | 315,250 | +213.4% | 0.00% | – |
| Q4 2013 | $1,921,000 | +56.9% | 100,578 | +34.3% | 0.00% | – |
| Q3 2013 | $1,224,000 | – | 74,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 218,515 | $2,045,000 | 12.79% |
| Broadfin Capital, LLC | 3,085,979 | $28,885,000 | 2.59% |
| First Light Asset Management, LLC | 467,743 | $4,378,000 | 1.88% |
| AWM Investment Company, Inc. | 1,005,000 | $9,407,000 | 1.72% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $2,340,000 | 0.77% |
| Grandeur Peak Global Advisors, LLC | 394,450 | $3,692,000 | 0.72% |
| TURNER INVESTMENTS LLC | 208,660 | $1,953,000 | 0.65% |
| WALL STREET ASSOCIATES | 197,400 | $1,848,000 | 0.63% |
| TFS CAPITAL LLC | 192,848 | $1,805,000 | 0.43% |
| GENERAL AMERICAN INVESTORS CO INC | 412,101 | $3,857,000 | 0.39% |